Different response to pulmonay vasoactive therapy in pulmonary hypertension due to lung diseases (group III PH)  Report from a pneumology based PH center

K. Heinig-Menhard (Gauting, Germany), C. Stoleriu (Gauting, Germany), M. Neiswirth (Gauting, Germany), J. Behr (Gauting, Germany), R. Göres (Munich, Germany), W. Gesierich (Munich, Germany), E. Silbernagel (Salzburg, Austria), F. Reichenberger (Munich, Germany)

Source: Virtual Congress 2020 – Pulmonary hypertension in lung diseases
Session: Pulmonary hypertension in lung diseases
Session type: E-poster session
Number: 296
Disease area: Pulmonary vascular diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
K. Heinig-Menhard (Gauting, Germany), C. Stoleriu (Gauting, Germany), M. Neiswirth (Gauting, Germany), J. Behr (Gauting, Germany), R. Göres (Munich, Germany), W. Gesierich (Munich, Germany), E. Silbernagel (Salzburg, Austria), F. Reichenberger (Munich, Germany). Different response to pulmonay vasoactive therapy in pulmonary hypertension due to lung diseases (group III PH)  Report from a pneumology based PH center. 296

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you: